Recent trends of polymer mediated liposomal gene delivery system

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kundu, Shyamal Kumar ^a,b   Sharma, Ashish Ranjan ^c   Lee, Sang Soo ^c   Sharma, Garima ^c   Doss, C George Priya ^d   Yagihara, Shin ^b   Kim, Do Young ^c   Nam, Ju Suk ^c   Chakraborty, Chiranjib ^a,c  

^a GALGOTIAS UNIVERSITY   (India)

^b TOKAI UNIVERSITY   (Japan)

^c Hallym University   (South Korea)

^d VIT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMER; LIPOSOME; MACROGOL; NANOPARTICLE; POLYMER; DNA; NANOCAPSULE;

ADRENOLEUKODYSTROPHY; BLINDNESS; DRUG FORMULATION; GENE DELIVERY SYSTEM; GENE THERAPY; HUMAN; IMMUNE DEFICIENCY; LIPOSOMAL DELIVERY; MOLECULAR WEIGHT; REVIEW; THALASSEMIA; X CHROMOSOME LINKED DISORDER; CHEMISTRY; DRUG DESIGN; GENETIC TRANSFECTION; GENETICS; PARTICLE SIZE; PROCEDURES; TRENDS; ULTRASTRUCTURE;

DNA; DRUG COMPOUNDING; DRUG DESIGN; LIPOSOMES; NANOCAPSULES; PARTICLE SIZE; POLYMERS; TRANSFECTION;

EID: 84924976261     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/934605     Document Type: Review

References (187)

1. E. L. Tatum, "Molecular biology, nucleic acids, and the future of medicine," Perspectives in Biology and Medicine, vol. 10, no. 1, pp. 19-32, 1966.
2. T. Friedmann, "Progress toward human gene therapy," Science, vol. 244, no. 4910, pp. 1275-1281, 1989.
3. P. L. Felgner and G. Rhodes, "Gene therapeutics," Nature, vol. 349, no. 6307, pp. 351-352, 1991.
4. R. C. Mulligan, "The basic science of gene therapy," Science, vol. 260, no. 5110, pp. 926-932, 1993.
5. A. D. Bangham, M. M. Standish, and J. C. Watkins, "Diffusion of univalent ions across the lamellae of swollen phospholipids.," Journal of Molecular Biology, vol. 13, no. 1, pp. 238-252, 1965.
6. L. D. Mayer, P. R. Cullis, and M. B. Bally, "The use of transmembrane pH gradient-driven drug encapsulation in the pharmacodynamic evaluation of liposomal doxorubicin," Journal of Liposome Research, vol. 4, no. 1, pp. 529-553, 1994.
7. D. D. Lasic, "Recent developments in medical applications of liposomes: sterically stabilized liposomes in cancer therapy and gene delivery in vivo," Journal of Controlled Release, vol. 48, no. 2-3, pp. 203-222, 1997.
8. A. S. Ulrich, "Biophysical aspects of using liposomes as delivery vehicles," Bioscience Reports, vol. 22, no. 2, pp. 129-150, 2002.
9. A. Kidane, G. C. Lantz, S. Jo, and K. Park, "Surface modification with PEO-containing triblock copolymer for improved biocompatibility: in vitro and ex vivo studies," Journal of Biomaterials Science, Polymer Edition, vol. 10, no. 10, pp. 1089-1105, 1999.
10. C. Monfardini and F. M. Veronese, "Stabilization of substances in circulation," Bioconjugate Chemistry, vol. 9, no. 4, pp. 418-450, 1998.
11. E. T. M. Dams, P. Laverman, W. J. G. Oyen et al., "Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes," Journal of Pharmacology and Experimental Therapeutics, vol. 292, no. 3, pp. 1071-1079, 2000.
12. M. T. Peracchia, E. Fattal, D. Desmaële et al., "Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting," Journal of Controlled Release, vol. 60, no. 1, pp. 121-128, 1999.
13. M. C. Woodle, "Controlling liposome blood clearance by surface-grafted polymers," Advanced Drug Delivery Reviews, vol. 32, no. 1-2, pp. 139-152, 1998.
14. C. R. O'Riordan, A. Lachapelle, C. Delgado et al., "PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo," Human Gene Therapy, vol. 10, no. 8, pp. 1349-1358, 1999.
15. D. Bhadra, S. Bhadra, P. Jain, and N. K. Jain, "Pegnology: a review of PEG-ylated systems," Pharmazie, vol. 57, no. 1, pp. 5-29, 2002.
16. A. V. Kabanov and V. A. Kabanov, "Interpolyelectrolyte and block ionomer complexes for gene delivery: physico-chemical aspects," Advanced Drug Delivery Reviews, vol. 30, no. 1-3, pp. 49-60, 1998.
17. P. Lemieux, S. V. Vinogradov, C. L. Gebhart et al., "Block and graft copolymers and Nanogel(TM) copolymer networks for DNA delivery into cell," Journal of Drug Targeting, vol. 8, no. 2, pp. 91-105, 2000.
18. J. M. Metselaar, P. Bruin, L. W. T. De Boer et al., "A novel family of L-amino acid-based biodegradable polymerlipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity," Bioconjugate Chemistry, vol. 14, no. 6, pp. 1156-1164, 2003.
19. M. L. Immordino, F. Dosio, and L. Cattel, "Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential," International Journal of Nanomedicine, vol. 1, no. 3, pp. 297-315, 2006.
20. A. D. Bangham and R. W. Horne, "Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope," Journal of Molecular Biology, vol. 8, no. 5, pp. 660-668, 1964.
21. R. W. Horne, A. D. Bangham, and V. P. Whittaker, "Negatively stained lipoprotein membranes," Nature, vol. 200, no. 4913, article 1340, 1963.
22. A. D. Bangham and R. W. Horne, "Action of saponin on biological cell membranes," Nature, vol. 196, no. 4858, pp. 952-953, 1962.
23. D.-G. Margineanu, "Equilibrium and non-equilibrium approaches in biomembrane thermodynamics," Archives Internationales de Physiologie et de Biochimie, vol. 95, no. 5, pp. 381-422, 1987.
24. S. Svetina and B. Zeks, "Shape behavior of lipid vesicles as the basis of some cellular processes," Anatomical Record, vol. 268, no. 3, pp. 215-225, 2002.
25. M. Shimomura and T. Sawadaishi, "Bottom-up strategy of materials fabrication: a new trend in nanotechnology of soft materials," Current Opinion in Colloid and Interface Science, vol. 6, no. 1, pp. 11-16, 2001.
26. A. M. D. Houslay and K. K. Stanley, Eds., Dynamics of Biological Membranes, Wiley Interscience Publications, John Wiley & Sons, New York, NY, USA, 1982.
27. S. K. Kundu, S. G. Choe, W. Yamamoto, R. Kita, and S. Yagihara, "Dielectric relaxation and dynamic light scattering study of liposome in the asqueous solution," in Material Research Society Symposium Proceedings, vol. 1019, pp. FF04-FF08, 2007.
28. F. Szoka Jr. and D. Papahadjopoulos, "Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation," Proceedings of the National Academy of Sciences of the United States of America, vol. 75, no. 9, pp. 4194-4198, 1978.
29. R. L. Shew and D. W. Deamer, "A novel method for encapsulation of macromolecules in liposomes," Biochimica et Biophysica Acta: Biomembranes, vol. 816, no. 1, pp. 1-8, 1985.
30. L. D. Mayer, M. B. Bally, and P. R. Cullis, "Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient," Biochimica et Biophysica Acta - Biomembranes, vol. 857, no. 1, pp. 123-126, 1986.
31. S. H. Hwang, Y. Maitani, X. Qi, K. Takayama, and T. Nagai, "Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods," International Journal of Pharmaceutics, vol. 179, no. 1, pp. 85-95, 1999.
32. E. M. Bolotin, R. Cohen, L. K. Bar et al., "Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes," Journal of Liposome Research, vol. 4, no. 1, pp. 455-479, 1994.
33. A. Jesorka and O. Orwar, "Liposomes: technologies and analytical applications," Annual Review of Analytical Chemistry, vol. 1, no. 1, pp. 801-832, 2008.
34. D. Lasic, Liposomes: From Physics to Applications, Elsevier, Amsterdam, The Netherlands, 1993.
35. V. P. Torchilin, "Recent advances with liposomes as pharmaceutical carriers," Nature Reviews Drug Discovery, vol. 4, no. 2, pp. 145-160, 2005.
36. S. Svetina, "Shape behavior of lipid vesicles as the basis of some cellular processes," Anatomical Record, vol. 268, no. 3, pp. 215-225, 2002.
37. C. Tros de Ilarduya, Y. Sun, and N. Düzgüneş, "Gene delivery by lipoplexes and polyplexes," European Journal of Pharmaceutical Sciences, vol. 40, no. 3, pp. 159-170, 2010.
38. I. Koltover, T. Salditt, and C. Safinya, "Phase diagram, stability, and overcharging of lamellar cationic lipid-DNA self-assembled complexes," Biophysical Journal, vol. 77, no. 2, pp. 915-924, 1999.
39. B. Sternberg, "New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy," FEBS Letters, vol. 356, no. 2-3, pp. 361-366, 1994.
40. I. Koltover, T. Salditt, J. O. Rädler, and C. R. Safinya, "An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery," Science, vol. 281, no. 5373, pp. 78-81, 1998.
41. J. O. Rädler, I. Koltover, T. Salditt, and C. R. Safinya, "Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes," Science, vol. 275, no. 5301, pp. 810-814, 1997.
42. J. Gustafsson, G. Arvidson, G. Karlsson, and M. Almgren, "Complexes between cationic liposomes and DNA visualized by cryo-TEM," Biochimica et Biophysica Acta - Biomembranes, vol. 1235, no. 2, pp. 305-312, 1995.
43. nd edition, 1991.
44. V. P. Torchilin, "Liposomes as targetable drug carriers," Critical Reviews in Therapeutic Drug Carrier Systems, vol. 2, no. 1, pp. 65-115, 1985.
45. A. L. Klibanov, K. Maruyama, V. P. Torchilin, and L. Huang, "Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes," The FEBS Letters, vol. 268, no. 1, pp. 235-237, 1990.
46. G. Blume and G. Cevc, "Molecularmechanism of the lipid vesicle longevity in vivo," Biochimica et Biophysica Acta: Biomembranes, vol. 1146, no. 2, pp. 157-168, 1993.
47. A. A. Gabizon, "Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new formof chemotherapy," Cancer Investigation, vol. 19, no. 4, pp. 424-436, 2001.
48. F. Martin and D. Lasic, Eds., Stealth Liposomes, CRC Press, Boca Raton, Fla, USA, 1995.
49. V. P. Torchilin, V. G. Omelyanenko, M. I. Papisov et al., "Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity," Biochimica et Biophysica Acta, vol. 1195, no. 1, pp. 11-20, 1994.
50. V. P. Torchilin and V. S. Trubetskoy, "Which polymers canmake nanoparticulate drug carriers long-circulating?" Advanced Drug Delivery Reviews, vol. 16, no. 2-3, pp. 141-155, 1995.
51. T. M. Allen and C. Hansen, "Pharmacokinetics of stealth versus conventional liposomes: effect of dose," Biochimica et Biophysica Acta - Biomembranes, vol. 1068, no. 2, pp. 133-141, 1991.
52. J. Zabner, A. J. Fasbender, T. Moninger, K. A. Poellinger, and M. J. Welsh, "Cellular and molecular barriers to gene transfer by a cationic lipid," Journal of Biological Chemistry, vol. 270, no. 32, pp. 18997-19007, 1995.
53. M. E. Dowty, P. Williams, G. Zhang, J. E. Hagstrom, and J. A. Wolff, "Plasmid DNA entry into postmitotic nuclei of primary rat myotubes," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 10, pp. 4572-4576, 1995.
54. P. Hug and R. G. Sleight, "Liposomes for the transformation of eukaryotic cells," Biochimica et Biophysica Acta - Molecular Basis of Disease, vol. 1097, no. 1, pp. 1-17, 1991.
55. J. A. Wolff, R. W. Malone, P. Williams, G. Acsadi, A. Jani, and P. L. Felgner, "Direct gene transfer into mouse muscle in vivo," Science, vol. 247, no. 4949, pp. 1465-1468, 1990.
56. J. A. Wolff, M. E. Dowty, S. Jiao et al., "Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle," Journal of Cell Science, vol. 103, no. 4, pp. 1249-1259, 1992.
57. M. Yoshida, R. I. Mahato, K. Kawabata, Y. Takakura, and M. Hashida, "Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system," Pharmaceutical Research, vol. 13, no. 4, pp. 599-603, 1996.
58. M. A. Hickman, R. W. Malone, K. Lehmann-Bruinsma et al., "Gene expression following direct injection of DNA into liver," Human Gene Therapy, vol. 5, no. 12, pp. 1477-1483, 1994.
59. M. van Borssum-Waalkes, M. van Galen, H. Morselt, B. Sternberg, and G. L. Scherphof, "In vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-29-deox-yuridine and its diacylated derivatives," Biochimica et Biophysica Acta, vol. 1148, no. 1, pp. 161-172, 1993.
60. O. Zelphati, E. Wagner, and L. Leserman, "Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester anti-sense oligonucleotides incorporated into immunoliposomes," Antiviral Research, vol. 25, no. 1, pp. 13-25, 1994.
61. nd edition, 1993.
62. P. L. Felgner and G. M. Ringold, "Cationic liposome-mediated transfection," Nature, vol. 337, no. 6205, pp. 387-388, 1989.
63. R. Leventis and J. R. Silvius, "Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles," Biochimica et Biophysica Acta: Biomembranes, vol. 1023, no. 1, pp. 124-132, 1990.
64. J. P. Behr, B. Demeneix, J. P. Loeffler, and J. Perez-Mutul, "Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA," Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 18, pp. 6982-6986, 1989.
65. I. Jääskeläinen, J. Mönkkönen, and A. Urtti, "Oligonucleotide-cationic lipid interactions: a physicochemical study," Biochimica et Biophysica Acta, vol. 1195, no. 1, pp. 115-123, 1994.
66. J. Zabner, A. J. Fasbender, T. Moninger, K. A. Poellinger, and M. J. Welsh, "Cellular and molecular barriers to gene transfer by a cationic lipid," The Journal of Biological Chemistry, vol. 270, no. 32, pp. 18997-19007, 1995.
67. I. Jääskeläinen, B. Sternberg, J. Mönkkönen, and A. Urtti, "Physicochemical and morphological properties of complexes made of cationic liposomes and oligonucleotides," International Journal of Pharmaceutical, vol. 167, no. 1-2, pp. 191-203, 1998.
68. G. J. Nabel, E. G. Nabel, Z. Yang et al., "Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans," Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11307-11311, 1993.
69. O. Boussif, F. Lezoual C'H, M. A. Zanta et al., "A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 16, pp. 7297-7301, 1995.
70. M. X. Tang, C. T. Redemann, and F. C. Szoka Jr., "In vitro gene delivery by degraded polyamidoamine dendrimers," Bioconjugate Chemistry, vol. 7, no. 6, pp. 703-714, 1996.
71. J. Haensler and F. C. Szoka Jr., "Polyamidoamine cascade polymers mediate efficient transfection of cells in culture," Bioconjugate Chemistry, vol. 4, no. 5, pp. 372-379, 1993.
72. M. X. Tang and F. C. Szoka, "The influence of polymer structure on the interactions of cationic polymers with DNA andmorphology of the resulting complexes," Gene Therapy, vol. 4, no. 8, pp. 823-832, 1997.
73. D. Needham, T. J. McIntosh, and D. D. Lasic, "Repulsive interactions and mechanical stability of polymer-grafted lipid membranes," Biochimica et Biophysica Acta, vol. 1108, no. 1, pp. 40-48, 1992.
74. M. DeCastro, Y. Saijoh, and G. C. Schoenwolf, "Optimized cationic lipid-based gene delivery reagents for use in developing vertebrate embryos," Developmental Dynamics, vol. 235, no. 8, pp. 2210-2219, 2006.
75. F. Shi, L. Wasungu, A. Nomden et al., "Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions," Biochemical Journal, vol. 366, no. 1, pp. 333-341, 2002.
76. H. Maeda, T. Sawa, and T. Konno, "Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS," Journal of Controlled Release, vol. 74, no. 1-3, pp. 47-61, 2001.
77. S. Zalipsky, M. Qazen, J. A. Walker II, N. Mullah, Y. P. Quinn, and S. K. Huang, "New detachable poly(ethylene glycol) conjugates: Cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine," Bioconjugate Chemistry, vol. 10, no. 5, pp. 703-707, 1999.
78. Z. Symon, A. Peyser, D. Tzemach et al., "Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes," Cancer, vol. 86, no. 1, pp. 72-78, 1999.
79. A. T. Perez, G. H. Domenech, C. Frankel, and C. L. Vogel, "Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network, Inc., experience," Cancer Investigation, vol. 20, supplement 2, pp. 22-29, 2002.
80. J. A. O'Shaughnessy, "Pegylated liposomal doxorubicin in the treatment of breast cancer," Clinical Breast Cancer, vol. 4, no. 5, pp. 318-328, 2003.
81. M. Schwonzen, C. M. Kurbacher, and P. Mallmann, "Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer," Anti-Cancer Drugs, vol. 11, no. 9, pp. 681-685, 2000.
82. A. Gonc¸alves, A. C. Braud, F. Viret et al., "Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors," Anticancer Research, vol. 23, no. 4, pp. 3543-3548, 2003.
83. K. J. Harrington, C. Lewanski, A. D. Northcote et al., "Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck," European Journal of Cancer, vol. 37, no. 16, pp. 2015-2022, 2001.
84. S. R. D. Johnston and M. E. Gore, "Caelyx: phase II studies in ovarian cancer," European Journal of Cancer, vol. 37, no. supplement 9, pp. S8-S14, 2001.
85. M. Schmidinger, C. Wenzel, G. J. Locker et al., "Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma," The British Journal of Cancer, vol. 85, no. 12, pp. 1850-1852, 2001.
86. U. Wollina, R. Dummer, N. H. Brockmeyer et al., "Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma," Cancer, vol. 98, no. 5, pp. 993-1001, 2003.
87. K. M. Skubitz, "Phase II trial of pegylated-liposomal doxorubicin (Doxil) in sarcoma," Cancer Investigation, vol. 21, no. 2, pp. 167-176, 2003.
88. M. V. Seiden, F. Muggia, A. Astrow et al., "A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer," Gynecologic Oncology, vol. 93, no. 1, pp. 229-232, 2004.
89. S. Sundar, T. K. Jha, C. P. Thakur, M. Mishra, V. P. Singh, and R. Buffels, "Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study," Clinical Infectious Diseases, vol. 37, no. 6, pp. 800-804, 2003.
90. G. J. Grant, Y. Barenholz, E. M. Bolotin et al., "A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia," Anesthesiology, vol. 101, no. 1, pp. 133-137, 2004.
91. D. E. Owens III and N. A. Peppas, "Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles,"International Journal of Pharmaceutics, vol. 307, no. 1, pp. 93-102, 2006.
92. F. M. Veronese and G. Pasut, "PEGylation, successful approach to drug delivery," Drug Discovery Today, vol. 10, no. 21, pp. 1451-1458, 2005.
93. J. M. Harris, Poly(ethylene glycol) Chemistry: Biotechnical and Biomedical Applications, Plenum Press, New York, NY, USA, 1992.
94. M. L. Adams, A. Lavasanifar, and G. S. Kwon, "Amphiphilic block copolymers for drug delivery," Journal of Pharmaceutical Sciences, vol. 92, no. 7, pp. 1343-1355, 2003.
95. N. Kumar, M. N. V. Ravikumar, and A. J. Domb, "Biodegradable block copolymers," Advanced Drug Delivery Reviews, vol. 53,no. 1, pp. 23-44, 2001.
96. M. Yokoyama, "Block copolymers as drug carriers," Critical Reviews in Therapeutic Drug Carrier Systems, vol. 9, no. 3-4, pp. 213-248, 1992.
97. D. B. Shenoy and M. M. Amiji, "Poly(ethylene oxide)-modified poly(ε-caprolactone) nanoparticles for targeted delivery of tamoxifen inbreast cancer," International Journal of Pharmaceutics, vol. 293, no. 1-2, pp. 261-270, 2005.
98. L. E. van Vlerken, T. K. Vyas, and M. M. Amiji, "Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery," Pharmaceutical Research, vol. 24, no. 8, pp. 1405-1414, 2007.
99. United States Food and Drug Administration, http://www.fda.gov/Drugs/default.htm.
100. T. Yamaoka, Y. Tabata, and Y. Ikada, "Distribution and tissue uptake of poly(ethylene glycol) with differentmolecularweights after intravenous administration to mice," Journal of Pharmaceutical Sciences, vol. 83, no. 4, pp. 601-606, 1994.
101. C. Monfardini, O. Schiavon, P. Caliceti, M. Morpurgo, J. M. Harris, and F. M. Veronese, "A branched monomethoxypoly(ethylene glycol) for protein modification," Bioconjugate Chemistry, vol. 6, no. 1, pp. 62-69, 1995.
102. M. Hamidi, A. Azadi, and P. Rafiei, "Pharmacokinetic consequences of pegylation," Drug Delivery, vol. 13, no. 6, pp. 399-409, 2006.
103. R. Gref, R. Gref, Y. Minamitake et al., "Biodegradable long-circulating polymeric nanospheres," Science, vol. 263, no. 5153, pp. 1600-1603, 1994.
104. R. Gref, A. Domb, P. Quellec et al., "The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres," Advanced Drug Delivery Reviews, vol. 16, no. 2-3, pp. 215-233, 1995.
105. S. M. Moghimi, H. Hedeman, I. S. Muir, L. Illum, and S. S. Davis, "An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen," Biochimica et Biophysica Acta, vol. 1157, no. 3, pp. 233-240, 1993.
106. S. M. Moghimi, A. C. Hunter, and J. C. Murray, "Long-circulating and target-specific nanoparticles: theory to practice," Pharmacological Reviews, vol. 53, no. 2, pp. 283-318, 2001.
107. S. Mao, M. Neu, O. Germershaus et al., "Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes," Bioconjugate Chemistry, vol. 17, no. 5, pp. 1209-1218, 2006.
108. S. Kommareddy and M. Amiji, "Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancerbearing mice," Journal of Pharmaceutical Sciences, vol. 96, no. 2, pp. 397-407, 2007.
109. B. Abdallah, A. Hassan, C. Benoist, D. Goula, J. P. Behr, and B. A. Demeneix, "A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine," Human Gene Therapy, vol. 7, no. 16, pp. 1947-1954, 1996.
110. M. P. Turunen, M. O. Hiltunen, M. Ruponen et al., "Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes," Gene Therapy, vol. 6, no. 1, pp. 6-11, 1999.
111. N. K. Egilmez, Y. Iwanuma, and R. B. Bankert, "Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer," Biochemical and Biophysical Research Communications, vol. 221, no. 1, pp. 169-173, 1996.
112. S. Ylä-Herttuala, H. Sumuvuori, K. Karkola, M. Möttönen, and T. Nikkari, "Glycosaminoglycans in normal and atherosclerotic human coronary arteries," Laboratory Investigation, vol. 54, no. 4, pp. 402-407, 1986.
113. T. N. Wight, D. K. Heinegård, and V. C. Hascall, "Proteoglycans; structure and function," in Cell Biology of Extracellular Matrix, E. D. Hay, Ed., pp. 45-78, Plenum Press, New York, NY, USA, 1991.
114. Y. Xu and F. C. Szoka Jr., "Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection,"Biochemistry, vol. 35, no. 18, pp. 5616-5623, 1996.
115. J.-P. Behr, B. Demeneix, J.-P. Loeffler, and J. Perez-Mutul, "Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA," Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 18, pp. 6982-6986, 1989.
116. O. Boussif, F. Lezoualc'h, M. A. Zanta et al., "A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine," Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 16, pp. 7297-7301, 1995.
117. M. X. Tang and F. C. Szoka, "The influence of polymer structure on the interactions of cationic polymers with DNA andmorphology of the resulting complexes," Gene Therapy, vol. 4, no. 8, pp. 823-832, 1997.
118. H. M. Temin, "Safety considerations in somatic gene therapy of human disease with retrovirus vectors," Human Gene Therapy, vol. 1, no. 2, pp. 111-123, 1990.
119. G. Y. Wu and C. H. Wu, "Receptor-mediated gene delivery and expression in vivo," The Journal of Biological Chemistry, vol. 263, no. 29, pp. 14621-14624, 1988.
120. E. Wagner, M. Zenke, M. Cotten, H. Beug, and M. L. Birnstiel, "Transferrin-polycation conjugates as carriers for DNA uptake into cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 9, pp. 3410-3414, 1990.
121. H. Farhood, R. Bottega, R. M. Epand, and L. Huang, "Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity," Biochimica et Biophysica Acta - Biomembranes, vol. 1111, no. 2, pp. 239-246, 1992.
122. N. J. Caplen, E. W. F. W. Alton, P. G. Middleton et al., "Liposome-mediated CFTR gene transfer to the nasal epitheliumof patients with cystic fibrosis," Nature Medicine, vol. 1, no. 3, pp. 39-46, 1995.
123. J. H. Felgner, R. Kumar, C. N. Sridhar et al., "Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations," Journal of Biological Chemistry, vol. 269, no. 4, pp. 2550-2561, 1994.
124. M. S. Wadhwa, D. L. Knoell, A. P. Young, and K. G. Rice, "Targeted gene delivery with a low molecular weight glycopeptide carrier," Bioconjugate Chemistry, vol. 6, no. 3, pp. 283-291, 1995.
125. G. Y. Wu and C. H. Wu, "Receptor-mediated in vitro gene transformation by a soluble DNA carrier system," The Journal of Biological Chemistry, vol. 262, no. 10, pp. 4429-4432, 1987.
126. C. H. Wu, J. M. Wilson, and G. Y. Wu, "Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo," The Journal of Biological Chemistry, vol. 264, no. 29, pp. 16985-16987, 1989.
127. H. C. Chiou, M. V. Tangco, S. M. Levine et al., "Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers," Nucleic Acids Research, vol. 22, no. 24, pp. 5439-5446, 1994.
128. X. Zhou, A. L. Klibanov, and L. Huang, "Lipophilic polylysines mediate efficient DNA transfection in mammalian cells," Biochimica et Biophysica Acta, vol. 1065, no. 1, pp. 8-14, 1991.
129. E. Wagner, C. Plank, K. Zatloukal, M. Cotten, and M. L. Birnstiel, "Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine- DNA complexes: toward a synthetic virus-like gene-transfer vehicle," Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 17, pp. 7934-7938, 1992.
130. V. S. Trubetskoy, V. P. Torchilin, S. J. Kennel, and L. Huang, "Use of N-terminalmodified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery inmouse lung endothelial cells," Bioconjugate Chemistry, vol. 3, no. 4, pp. 323-327, 1992.
131. P. Midoux, C. Mendes, A. Legrand et al., "Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells," Nucleic Acids Research, vol. 21, no. 4, pp. 871-878, 1993.
132. D. Martinez-Fong, J. E. Mullersman, A. F. Purchio, J Armendariz-Borunda, and A. Martinez-Hernandez, "Nonenzymatic glycosylation of poly-L-lysine: a new tool for targeted gene delivery," Hepatology, vol. 20, no. 6, pp. 1602-1608, 1994.
133. P. Erbacher, M. Bousser, J. Raimond, M. Monsigny, P. Midoux, and A. C. Roche, "Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages," Human Gene Therapy, vol. 7, no. 6, pp. 721-729, 1996.
134. J. Kim, A. Maruyama, T. Akaike, and S. W. Kim, "In vitro gene expression on smoothmuscle cells using a terplex delivery system," Journal of Controlled Release, vol. 47, no. 1, pp. 51-59, 1997.
135. M. A. Wolfert, E. H. Schacht, V. Toncheva, K. Ulbrich, O. Nazarova, and L. W. Seymour, "Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers," Human Gene Therapy, vol. 7, no. 17, pp. 2123-2133, 1996.
136. A. V. Kabanov, S. V. Vinogradov, Y. G. Suzdaltseva, and V. Y. Alakhov, "Water-soluble block polycations as carriers for oligonucleotide delivery," Bioconjugate Chemistry, vol. 6, no. 6, pp. 639-643, 1995.
137. Y. H. Choi, F. Liu, J. Kim, Y. K. Choi, J. S. Park, and S. W. Kim, "Polyethylene glycol-grafted poly-L-lysine as polymeric gene carder," Journal of Controlled Release, vol. 54, no. 1, pp. 39-48, 1998.
138. M. Ruponen, S. Ylä-Herttuala, and A. Urtti, "Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: Physicochemical and transfection studies," Biochimica et Biophysica Acta: Biomembranes, vol. 1415, no. 2, pp. 331-341, 1999.
139. T. Bronich, A. V. Kabanov, and L. A. Marky, "A thermodynamic characterization of the interaction of a cationic copolymer with DNA," Journal of Physical Chemistry B, vol. 105, no. 25, pp. 6042-6050, 2001.
140. S. Chesnoy and L. Huang, "DNA condensed by polycations and lipids for gene transfer," S.T.P. Pharma Sciences, vol. 9, no. 1, pp. 5-12, 1999.
141. Y. Capan, B. H. Woo, S. Gebrekidan, S. Ahmed, and P. P. deLuca, "Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA," Pharmaceutical Research, vol. 16, no. 4, pp. 509-513, 1999.
142. P. P. Karmali and A. Chaudhuri, "Cationic liposomes as non-viral carriers of genemedicines: resolved issues, open questions, and future promises," Medicinal Research Reviews, vol. 27, no. 5, pp. 696-722, 2007.
143. E. Mayhew and D. Papajadjopoulos, "Therapeutic applications of liposomes," in Liposomes, M. J. Ostro, Ed., pp. 289-341, Marcel Dekker, New York, NY, USA, 1983.
144. N. S. Templeton, "Cationic liposome-mediated gene delivery in vivo," Bioscience Reports, vol. 22, no. 2, pp. 283-295, 2002.
145. X. Gao and L. Huang, "Potentiation of cationic liposome-mediated gene delivery by polycations," Biochemistry, vol. 35, no. 3, pp. 1027-1036, 1996.
146. F. L. Sorgi, S. Bhattacharya, and L. Huang, "Protamine sulfate enhances lipid-mediated gene transfer," Gene Therapy, vol. 4, no. 9, pp. 961-968, 1997.
147. R. J. Lee and L. Huang, "Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer," Journal of Biological Chemistry, vol. 271, no. 14, pp. 8481-8487, 1996.
148. L. K. Lee, C. L. Williams, D. Devore, and C. M. Roth, "Poly(propylacrylic acid) enhances cationic lipid-mediated delivery of antisense oligonucleotides," Biomacromolecules, vol. 7, no. 5, pp. 1502-1508, 2006.
149. S. Li and L. Huang, "In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes," Gene Therapy, vol. 4, no. 9, pp. 891-900, 1997.
150. E. A. Murphy, A. J. Waring, S. M. Haynes, and K. J. Longmuir, "Compaction of DNA in an anionic micelle environment followed by assembly into phosphatidylcholine liposomes," Nucleic Acids Research, vol. 28, no. 15, pp. 2986-2992, 2000.
151. E. A. Murphy, A. J. Waring, J. C. Murphy, R. C. Willson, and K. J. Longmuir, "Development of an effective gene delivery system: a study of complexes composed of a peptide-based amphiphilic DNA compaction agent and phospholipid," Nucleic Acids Research, vol. 29, no. 17, pp. 3694-3704, 2001.
152. K. J. Longmuir, S. M. Haynes, M. E. Dickinson, J. C. Murphy, R. C. Willson, and A. J. Waring, "Optimization of a peptide/non-cationic lipid gene delivery system for effective microinjection into chicken embryo in vivo," Molecular Therapy, vol. 4, no. 1, pp. 66-74, 2001.
153. V. L. Makarov, Y. Hirose, and J. P. Langmore, "Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening," Cell, vol. 88, no. 5, pp. 657-666, 1997.
154. F. W. Smith and J. Feigon, "Quadruplex structure of Oxytricha telomeric DNA oligonucleotides," Nature, vol. 356, no. 6365, pp. 164-168, 1992.
155. J. T. Davis, "G-quartets 40 years later: from 5′-GMP to molecular biology and supramolecular chemistry," Angewandte Chemie International Edition, vol. 43, no. 6, pp. 668-698, 2004.
156. D. J. Patel, A. T. Phan, and V. Kuryavyi, "Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics," Nucleic Acids Research, vol. 35, no. 22, pp. 7429-7455, 2007.
157. S. Neidle, "The structures of quadruplex nucleic acids and their drug complexes," Current Opinion in Structural Biology, vol. 19, no. 3, pp. 239-250, 2009.
158. M. Gellert, M. N. Lipsett, and D. R. Davies, "Helix formation by guanylic acid.," Proceedings of the National Academy of Sciences of the United States of America, vol. 48, no. 12, pp. 2013-2018, 1962.
159. K. Paeschke, T. Simonsson, J. Postberg, D. Rhodes, and H. J. Lipps, "Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo," Nature Structural and Molecular Biology, vol. 12, no. 10, pp. 847-854, 2005.
160. N. Maizels, "Dynamic roles for G4 DNA in the biology of eukaryotic cells," Nature Structural and Molecular Biology, vol. 13, no. 12, pp. 1055-1059, 2006.
161. D. Sun, B. Thompson, B. E. Cathers et al., "Inhibition of human telomerase by a G-Quadruplex-Interactive compound," Journal of Medicinal Chemistry, vol. 40, no. 14, pp. 2113-2116, 1997.
162. J. L. Mergny and C. Helene, "G-quadruplex DNA: a target for drug design," Nature Medicine, vol. 4, no. 12, pp. 1366-1367, 1998.
163. A. M. Zahler, J. R. Williamson, T. R. Cech, and D. M. Prescott, "Inhibition of telomerase by G-quartet DNA structures," Nature, vol. 350, no. 6320, pp. 718-720, 1991.
164. L. Oganesian, I. K. Moon, T. M. Bryan, and M. B. Jarstfer, "Extension of G-quadruplex DNA by ciliate telomerase," EMBO Journal, vol. 25, no. 5, pp. 1148-1159, 2006.
165. N. W. Kim, M. A. Piatyszek, K. R. Prowse et al., "Specific association of human telomerase activity with immortal cells and cancer," Science, vol. 266, no. 5193, pp. 2011-2015, 1994.
166. S. B. Zimmerman and S. O. Trach, "Estimation of macromolecule concentrations and excluded volume effects for the cytoplasmof Escherichia coli," Journal of Molecular Biology, vol. 222, no. 3, pp. 599-620, 1991.
167. R. J. Ellis and A. P. Minton, "Cell biology: join the crowd,"Nature, vol. 425, pp. 27-28, 2003.
168. H. Zhou, G. Rivas, and A. P. Minton, "Macromolecular crowding and confinement: biochemical, biophysical, and potential physiological consequences," Annual Review of Biophysics, vol. 37, pp. 375-397, 2008.
169. D. Miyoshi and N. Sugimoto, "Molecular crowding effects on structure and stability of DNA," Biochimie, vol. 90, no. 7, pp. 1040-1051, 2008.
170. D. Miyoshi, A. Nakao, and N. Sugimoto, "Molecular crowding regulates the structural switch of the DNA G-quadruplex,"Biochemistry, vol. 41, no. 50, pp. 15017-15024, 2002.
171. J. Li, J. J. Correia, L. Wang, J. O. Trent, and J. B. Chaires, "Not so crystal clear: the structure of the human telomere G-quadruplex in solution differs from that present in a crystal," Nucleic Acids Research, vol. 33, no. 14, pp. 4649-4659, 2005.
172. D. Miyoshi, H. Karimata, and N. Sugimoto, "Hydration regulates thermodynamics of G-quadruplex formation under molecular crowding conditions," Journal of the American Chemical Society, vol. 128, no. 24, pp. 7957-7963, 2006.
173. M. Vorlíčková, K. Bednářová, I. Kejnovská, and J. Kypr, "Intramolecular and intermolecular guanine quadruplexes of DNA in aqueous salt and ethanol solutions," Biopolymers, vol. 86, no. 1, pp. 1-10, 2007.
174. + solution under molecular crowding condition," Journal of the American Chemical Society, vol. 129, no. 36, pp. 11185-11191, 2007.
175. P. Balagurumoorthy, S. K. Brahmachari, D. Mohanty, M. Bansal, and V. Sasisekharan, "Hairpin and parallel quartet structures for telomeric sequences," Nucleic Acids Research, vol. 20, no. 15, pp. 4061-4067, 1992.
176. M. C. Miller, R. Buscaglia, J. B. Chaires, A. N. Lane, and J. O. Trent, "Hydration is a major determinant of the G-quadruplex stability and conformation of the human telomere 3′ sequence of d(AG 3(TTAG3)3)," Journal of the American Chemical Society, vol. 132, no. 48, pp. 17105-17107, 2010.
177. G. N. Parkinson, M. P. H. Lee, and S. Neidle, "Crystal structure of parallel quadruplexes from human telomeric DNA," Nature, vol. 417, no. 6891, pp. 876-880, 2002.
178. B. Heddi and A. T. Phan, "Structure of human telomeric DNA in crowded solution," Journal of the American Chemical Society, vol. 133, no. 25, pp. 9824-9833, 2011.
179. X. Liang, X. Li, J. Chang, Y. Duan, and Z. Li, "Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery," Langmuir, vol. 29, no. 27, pp. 8683-8693, 2013.
180. K. von Gersdorff, N. N. Sanders, R. Vandenbroucke, S. C. de Smedt, E. Wagner, and M. Ogris, "The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type," Molecular Therapy, vol. 14, no. 5, pp. 745-753, 2006.
181. J. Rejman, A. Bragonzi, and M. Conese, "Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes," Molecular Therapy, vol. 12, no. 3, pp. 468-474, 2005.
182. M. A. E. M. van der Aa, U. S. Huth, S. Y. Häfele et al., "Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells," Pharmaceutical Research, vol. 24, no. 8, pp. 1590-1598, 2007.
183. H. Hufnagel, P. Hakim, A. Lima, and F. Hollfelder, "Fluid phase endocytosis contributes to transfection of DNA by PEI-25," Molecular Therapy, vol. 17, no. 8, pp. 1411-1417, 2009.
184. H. Hatakeyama, H. Akita, and H. Harashima, "The polyethyl-eneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors," Biological and Pharmaceutical Bulletin, vol. 36, no. 6, pp. 892-899, 2013.
185. C. S. Manno, V. R. Arruda, G. F. Pierce et al., "Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response," Nature Medicine, vol. 12, no. 3, pp. 342-347, 2006.
186. F. Mingozzi, J. J. Meulenberg, D. J. Hui et al., "AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells," Blood, vol. 114, no. 10, pp. 2077-2086, 2009.
187. A. R. Sharma, S. K. Kundu, J. S. Nam et al., "Next generation delivery system for proteins and genes of therapeutic purpose: why and how?" BioMed Research International, vol. 2014, Article ID 327950, 11 pages, 2014.